Description
An active metabolite of clindamycin; formed via S-oxidation of clindamycin primarily by CYP3A4; inhibits the growth of P. prevotti, B. fragilis, and C. sordelli in vitro (MICs = 2, 2, and 1 mg/L, respectively)
Formal name: 7-chloro-1,6,7,8-tetradeoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-(methylsulfinyl)-L-threo-α-D-galacto-octopyranose
Synonyms: U-25026A
Molecular weight: 441
CAS: 22431-46-5
Purity: ≥90% (mixture of diastereomers)
Formulation: A solid
Product Type|Biochemicals|Antibiotics||Product Type|Biochemicals|Antiparasitics|Antiprotozoals||Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases||Research Area|Infectious Disease|Parasitic Diseases|Malaria||Research Area|Toxicology|Drug Metabolism